policy
National Animal Health Laboratory Network (NAHLN) funding
The AVMA advocates for funding to develop and maintain infrastructure for a comprehensive National Animal Health Laboratory Network so that the U.S.…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Veterinary diagnostic laboratory funding
The AVMA encourages ongoing funding and support to develop and maintain monitoring, surveillance, and surge capacity within the Integrated Consortium…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Joint AVMA-FVE-CVMA statement on the benefits of animal vaccination programs in advancing animal and human health
This statement has been adopted jointly by the AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association.
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
JAVMA news
Second virtual National Veterinary Scholars Symposium draws 900
The National Veterinary Scholars Symposium for student researchers, hosted by Iowa State University College of Veterinary Medicine this year, went…
policy
Vaccination principles
Vaccines have been proven highly efficacious and beneficial to the health of veterinary patients, as well as the general public. Decisions about…
JAVMA news
The risky business of global animal movement
Likely sources of another pandemic are being scrutinized like never before, including the global movement of animals via international trade and…